Big Move For TransCode Therapeutics Inc.
Thu, May 09, 2024 at 07:28 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) jumped higher at $1.33, a gain of 30.4%. On Thu, May 09, 2024, RNAZ:NASDAQ touched a New 2-Week High of $1.33. The stock appeared on our News Catalysts scanner on Mon, Apr 15, 2024 at 10:51 AM in the 'BIOTECH' category. From Thu, Apr 25, 2024, the stock recorded 80.00% Up Days and 72.73% Green Days
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Pop Culture Group Co. Ltd (CPOP:NASDAQ), 84.62%
- Sezzle Inc. (SEZL:NASDAQ), 75.66%
- Embecta Corp. (EMBC:NASDAQ), 37.88%
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 37.44%
- Safe and Green Development Corporation (SGD:NASDAQ), 36.73%
- Consensus Cloud Solutions Inc. (CCSI:NASDAQ), 36.05%
- BRC Inc. Class A (BRCC:NYSE), 31.22%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 30.39%
- Telephone and Data Systems, Inc. (TDS:NYSE), 28.63%
- SiTime Corporation (SITM:NASDAQ), 28.29%